Tenecteplase in Stroke Patients Between 4.5 and 24 Hours
Clinical trial NCT03785678 · COMPLETED
Trial details
- NCT number
- NCT03785678
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-02
- Primary completion
- 2023-02-28
- Enrollment
- 458
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.